Nationwide registry study reveals a 5.7% prevalence of auditory late effects in pediatric cancer survivors, highlighting the need for early hearing monitoring in young patients.
Key Points
To estimate the nationwide prevalence and clinical patterns of auditory late effects among children and adolescents diagnosed with cancer.
Nationwide registry study evaluating linked records from the Danish Cancer Register and Danish National Patient Register for patients diagnosed under age 18 between 2014 and 2024 (N=3,075).
Assessed associations between cancer diagnosis and auditory outcomes using descriptive statistics, chi-square tests, relative risks, and trend analyses.
Auditory late effects, including hearing loss and tinnitus, occurred in 5.7% of the childhood cancer survivor cohort.
Patients diagnosed at a younger age, those with malignant neoplasms, and recipients of high-dose chemotherapy at an early age exhibited an increased risk of auditory complications.